Correlation Between Voyager Therapeutics and Cingulate Warrants
Can any of the company-specific risk be diversified away by investing in both Voyager Therapeutics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Voyager Therapeutics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Voyager Therapeutics and Cingulate Warrants, you can compare the effects of market volatilities on Voyager Therapeutics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Voyager Therapeutics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Voyager Therapeutics and Cingulate Warrants.
Diversification Opportunities for Voyager Therapeutics and Cingulate Warrants
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Voyager and Cingulate is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Voyager Therapeutics and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and Voyager Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Voyager Therapeutics are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of Voyager Therapeutics i.e., Voyager Therapeutics and Cingulate Warrants go up and down completely randomly.
Pair Corralation between Voyager Therapeutics and Cingulate Warrants
Given the investment horizon of 90 days Voyager Therapeutics is expected to generate 791.75 times less return on investment than Cingulate Warrants. But when comparing it to its historical volatility, Voyager Therapeutics is 24.72 times less risky than Cingulate Warrants. It trades about 0.0 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 24.00 in Cingulate Warrants on November 2, 2024 and sell it today you would lose (18.80) from holding Cingulate Warrants or give up 78.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 78.14% |
| Values | Daily Returns |
Voyager Therapeutics vs. Cingulate Warrants
Performance |
| Timeline |
| Voyager Therapeutics |
| Cingulate Warrants |
Voyager Therapeutics and Cingulate Warrants Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Voyager Therapeutics and Cingulate Warrants
The main advantage of trading using opposite Voyager Therapeutics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Voyager Therapeutics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.| Voyager Therapeutics vs. Day One Biopharmaceuticals | Voyager Therapeutics vs. X4 Pharmaceuticals | Voyager Therapeutics vs. Inozyme Pharma | Voyager Therapeutics vs. Acumen Pharmaceuticals |
| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |